V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009910 | 190007822 | 1.52 | 62.7 | null | 2016-01-05 | 2016-06-18 | ETOPOSIDE + IFOSFAMIDE | null | null | ETOPOSIDE + IFOSFAMIDE | 101791109 |
| 190009917 | 190007823 | 1.79 | 13.2 | Neo-adjuvant (N) | 2021-06-28 | 2022-01-05 | Docetaxel + Gemcitabine (prior RT) | null | null | DOCETAXEL + GEMCITABINE | 100316004 |
| 190009931 | 190007824 | 1.9 | 33.5 | Curative (C) | 2021-03-09 | 2021-09-02 | EC | Y | N | DOXORUBICIN + METHOTREXATE | 100621537 |
| 190009950 | 190007825 | 1.73 | 65 | null | null | 2020-05-12 | Cyclophosphamide + Topotecan | null | null | DHAP | 100607227 |
| 190010002 | 190007826 | 0 | 46.3 | Adjuvant (A) | 2019-10-06 | 2020-04-01 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100064157 |
| 190010035 | 190007827 | 0 | 60.4 | Curative (C) | 2020-11-27 | 2020-11-30 | DOCETAXEL + GEMCITABINE | Y | N | DOCETAXEL + GEMCITABINE | 101667228 |
| 190010044 | 190007828 | 1.71 | 36.1 | Neo-adjuvant (N) | 2022-04-02 | 2022-04-04 | NB HRNBL-1 Isotretinoin | 02 | null | GEMCITABINE | 101484428 |
| 190010085 | 190007829 | null | 66.3 | Palliative (P) | 2016-12-26 | 2016-12-27 | Ifosfamide PVI 1g/m2 14day | null | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100022744 |
| 190010091 | 190007830 | 0 | 33.4 | Palliative (P) | 2020-10-15 | 2020-10-16 | Capecitabine + Cisplatin | 02 | N | TRIAL | 101727589 |
| 190010093 | 190007831 | 0 | 43.4 | Palliative (P) | 2021-11-22 | 2022-02-05 | EURO-EWING | 01 | N | STS NON-RHABDO EPSSG 2005 VDC/IE | 101125124 |
| 190010117 | 190007833 | 1.54 | 68 | Curative (C) | 2021-08-29 | 2021-09-05 | null | 02 | null | NB BEACON TEMOZOLOMIDE AND IRINOTECAN | 100494715 |
| 190010122 | 190007834 | 1.74 | 66.3 | Curative (C) | 2019-04-26 | 2019-05-24 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100562215 |
| 190010126 | 190007835 | 1.74 | 62.1 | Curative (C) | 2020-10-01 | 2020-11-05 | DOXORUBICIN | 01 | N | DOXORUBICIN | 100810176 |
| 190010128 | 190007836 | 0 | 0 | null | 2020-10-02 | 2020-11-04 | Paclitaxel albumin (Abraxane) 21day | 02 | null | NIVOLUMAB | 101335572 |
| 190010150 | 190007837 | 0 | 20.5 | Palliative (P) | 2019-01-21 | 2019-04-23 | Etoposide + Ifosfamide (5 days) | 01 | Y | ETOPOSIDE + IFOSFAMIDE | 100080628 |
| 190010254 | 190007838 | 1.66 | 32 | Palliative (P) | 2017-11-05 | 2018-02-25 | EURAMOS TRIAL | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | 101655316 |
| 190010259 | 190007839 | 1.6 | 64.6 | Curative (C) | 2019-10-01 | 2019-10-08 | Capecitabine + Oxaliplatin 21day | 02 | null | ETOPOSIDE + IFOSFAMIDE + METHOTREXATE | 101864734 |
| 190010293 | 190007840 | 0 | 84 | Palliative (P) | 2018-12-27 | 2019-05-31 | CAPECITABINE + OXALIPLATIN | 02 | null | DOXORUBICIN + METHOTREXATE | 101826975 |
| 190010295 | 190007841 | 0 | 61 | Adjuvant (A) | 2021-02-07 | 2021-08-10 | OST Euramos 1 Closed Trial - A | N | N | OST A | 101658414 |
| 190010298 | 190007842 | 1.65 | 103.8 | Palliative (P) | 2018-04-14 | 2018-04-24 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | EW EUROEWING 2012 ARM B VDC/IE | 101616146 |
| 190010347 | 190007843 | 1.54 | 67.5 | Palliative (P) | 2016-03-09 | 2017-05-26 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100457965 |
| 190010360 | 190007845 | 0 | 88 | Curative (C) | 2020-02-09 | 2020-02-10 | MAP | 01 | N | OST IE | 100086863 |
| 190010375 | 190007846 | 1.79 | 38.9 | null | 2021-06-13 | 2022-01-15 | Gemcitabine + Capecitabine | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 100484423 |
| 190010413 | 190007847 | 1.88 | 20.3 | null | 2017-11-15 | 2020-08-27 | Liposomal Doxorubicin (Caelyx) | 02 | null | VAI | 101790227 |
| 190010414 | 190007848 | 0 | 56.9 | Curative (C) | 2017-04-18 | 2017-07-16 | BUSULFAN + MELPHALAN | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 100303566 |
| 190010453 | 190007849 | 1.6 | 70.5 | Curative (C) | 2020-06-21 | 2020-07-22 | Cisplatin + Radiotherapy | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100633818 |
| 190010459 | 190007850 | 0 | 37 | null | 2019-10-12 | 2020-02-09 | Topotecan (oral) | 02 | N | EW EUROEWING 2012 ARM B VDC | 101317669 |
| 190010473 | 190007851 | 1.47 | null | Neo-adjuvant (N) | 2021-03-07 | 2021-03-07 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100010762 |
| 190010480 | 190007852 | 1.55 | 70.2 | Palliative (P) | 2017-10-10 | 2017-10-28 | MAP | 02 | N | VAI | 101828403 |
| 190010500 | 190007853 | null | 101.6 | Palliative (P) | 2020-09-14 | 2020-09-17 | DOXORUBICIN | 01 | N | DOXORUBICIN | 101662835 |
| 190010509 | 190007854 | 0 | 105 | Curative (C) | 2018-01-29 | 2018-02-19 | DOCETAXEL + GEMCITABINE | 02 | null | DOCETAXEL + GEMCITABINE | 100277654 |
| 190010510 | 190007855 | 1.87 | 104.2 | Curative (C) | 2018-01-26 | 2018-04-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101045967 |
| 190010523 | 190007856 | 1.6 | 50.7 | Palliative (P) | 2016-01-23 | 2016-09-09 | CAPECITABINE + CARBOPLATIN | 01 | N | NB HRNBL-1 COJEC IND COURSE B | 100632183 |
| 190010554 | 190007857 | 0 | 25.6 | null | 2019-01-01 | 2019-01-05 | OST Euramos 1 Closed Trial - M | 01 | null | OST M | 101448429 |
| 190010589 | 190007858 | 0 | 29.2 | null | 2016-11-09 | 2017-03-21 | DHAP | 02 | null | EURO-EWING | 100945629 |
| 190010621 | 190007860 | 1.74 | 62.5 | Curative (C) | 2016-07-10 | 2016-09-22 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100869513 |
| 190010631 | 190007861 | 0 | 43.4 | Palliative (P) | 2020-11-01 | 2021-03-25 | ETOPOSIDE + IFOSFAMIDE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101376355 |
| 190010645 | 190007862 | 0 | 43 | Curative (C) | 2022-03-16 | 2022-03-16 | LIPOSOMAL DOXORUBICIN | 02 | null | DOXORUBICIN + METHOTREXATE | 101482072 |
| 190010650 | 190007863 | 1.47 | 72.4 | Palliative (P) | 2018-10-02 | 2018-10-03 | Capecitabine (14 days)+Carboplatin | 02 | Y | IFOSFAMIDE | 100561190 |
| 190010677 | 190007864 | 1.73 | 57 | Palliative (P) | 2019-03-17 | 2019-07-10 | ETOPOSIDE + IFOSFAMIDE | 01 | null | ETOPOSIDE + IFOSFAMIDE | 101071807 |
| 190010685 | 190007865 | 1.58 | 36 | Curative (C) | 2022-01-09 | 2022-01-30 | CARBOPLATIN + RT | 02 | N | DOXORUBICIN + METHOTREXATE | 101159852 |
| 190010710 | 190007866 | 0 | 79.65 | Palliative (P) | 2022-04-28 | 2022-05-02 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101002130 |
| 190010719 | 190007867 | 1.77 | 75.2 | null | 2018-10-05 | 2018-10-05 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100144097 |
| 190010739 | 190007868 | 1.7 | null | null | null | 2018-04-16 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100569513 |
| 190010755 | 190007869 | null | 55.3 | null | 2018-10-10 | 2019-01-02 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101847115 |
| 190010800 | 190007870 | 0 | 23.3 | Palliative (P) | 2017-07-21 | 2017-08-06 | Doxorubicin 75mg/m2 | null | null | DOXORUBICIN | 100086834 |
| 190010837 | 190007871 | 1.82 | 42.5 | Curative (C) | 2019-09-05 | 2019-09-05 | Oxaliplatin + Modified de Gramont | 02 | null | DOXORUBICIN + METHOTREXATE | 101586453 |
| 190010853 | 190007872 | 0 | 59 | Curative (C) | 2020-07-06 | 2020-08-03 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 100377460 |
| 190010859 | 190007873 | 1.55 | 62.55 | Adjuvant (A) | 2020-07-31 | 2021-01-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100146635 |
| 190010888 | 190007874 | 1.64 | 50.5 | null | 2017-03-10 | 2017-07-16 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101759564 |